Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels |
|---|---|---|---|
| 1 | |||
| Flushing | 40% | 6% | x |
| Abdominal pain | 18% | 10% | x |
| Diarrhoea | 14% | 11% | x |
| Nausea | 12% | 9% | x |
| Vomiting | 9% | 5% | x |
| Rash | 8% | 3% | x |
| Pruritus | 8% | 4% | x |
| Albumin urine present | 6% | 4% | x |
| Dyspepsia | 5% | 3% | x |
| Erythema | 5% | 1% | x |
| Aspartate aminotransferase increased | 4% | 2% | x |
| Lymphopenia | 2% | 1% | x |
| Eosinophilia | x | ||
| Gastrointestinal disorder | x | ||
| Angiopathy | x | ||
| Unspecified disorder of skin and subcutaneous tissue | x | ||
| Blood and lymphatic system disorders | x | ||
No indications were found.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |